Cargando…

Association between Variant Y402H in Age-Related Macular Degeneration (AMD) Susceptibility Gene CFH and Treatment Response of AMD: A Meta-Analysis

PURPOSE: To investigate the association between polymorphism rs1061170 (T1277C, Y402H) in age-related macular degeneration (AMD) susceptibility gene Complement Factor H (CFH) and treatment response of neovascular AMD. METHODS: We performed a literature-based meta-analysis including 10 published asso...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Han, Yu, Ke-Da, Xu, Ge-Zhi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419212/ https://www.ncbi.nlm.nih.gov/pubmed/22905135 http://dx.doi.org/10.1371/journal.pone.0042464

Ejemplares similares

CFH Y402H Confers Similar Risk of Soft Drusen and Both Forms of Advanced AMD
por: Magnusson, Kristinn P, et al.
Publicado: (2006)

The effect of CFH polymorphisms on the response to the treatment of age-related macular degeneration (AMD) with intravitreal ranibizumab
por: Dikmetas, Ozlem, et al.
Publicado: (2013)

Retinal Vessel Functionality Is Linked With ARMS2 A69S and CFH Y402H Polymorphisms and Choroidal Status in AMD Patients
por: Krytkowska, Elżbieta, et al.
Publicado: (2021)

Association between CFH Y402H Polymorphism and Age Related Macular Degeneration in North Indian Cohort
por: Sharma, Neel Kamal, et al.
Publicado: (2013)

Matrix Metalloproteinases in Age-Related Macular Degeneration (AMD)
por: García-Onrubia, Luis, et al.
Publicado: (2020)

Comprehensive analysis of CRP, CFH Y402H and environmental risk factors on risk of neovascular age-related macular degeneration
por: Kim, Ivana K., et al.
Publicado: (2008)

A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration
por: Sivakumaran, Theru A., et al.
Publicado: (2011)

Artificial Intelligence to Stratify Severity of Age-Related Macular Degeneration (AMD) and Predict Risk of Progression to Late AMD
por: Bhuiyan, Alauddin, et al.
Publicado: (2020)

Sex Differences in RANTES (CCL5) in Patients With Intermediate Age-Related Macular Degeneration (AMD) and Controls With no AMD
por: Fonteh, Cheryl N., et al.
Publicado: (2022)

The role of lipocalin-2 in age-related macular degeneration (AMD)
por: Ghosh, Sayan, et al.
Publicado: (2020)

Age-Related Macular Degeneration (AMD): A View to the Future
por: Miller, Joan W., et al.
Publicado: (2021)

Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD)
por: Nashine, Sonali
Publicado: (2021)

Correction: A 32 kb Critical Region Excluding Y402H in CFH Mediates Risk for Age-Related Macular Degeneration
por: Sivakumaran, Theru A., et al.
Publicado: (2018)

Screening of CRISPR/Cas base editors to target the AMD high-risk Y402H complement factor H variant
por: Tran, Minh Thuan Nguyen, et al.
Publicado: (2019)

Age-Related Macular Degeneration: New Paradigms for Treatment and Management of AMD
por: Hernández-Zimbrón, Luis Fernando, et al.
Publicado: (2018)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

Linking Adiponectin and Its Receptors to Age-Related Macular Degeneration (AMD)
por: Choubey, Mayank, et al.
Publicado: (2023)

Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
por: Varano, Monica, et al.
Publicado: (2015)

Associations of MicroRNAs, Angiogenesis-Regulating Factors and CFH Y402H Polymorphism—An Attempt to Search for Systemic Biomarkers in Age-Related Macular Degeneration
por: Ulańczyk, Zofia, et al.
Publicado: (2019)

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji, Tsuyoshi, et al.
Publicado: (2013)

New and Innovative Treatments for Neovascular Age-Related Macular Degeneration (nAMD)
por: Patel, Prem, et al.
Publicado: (2021)

Effect of Humanin G (HNG) on inflammation in age-related macular degeneration (AMD)
por: Nashine, Sonali, et al.
Publicado: (2022)

Pharmacogenetics of Complement Factor H Y402H Polymorphism and Treatment of Neovascular AMD with Anti-VEGF Agents: A Meta-Analysis
por: Chen, Guohai, et al.
Publicado: (2015)

Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management
por: Amini, Mohammad Amin, et al.
Publicado: (2023)

CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD
por: Scholl, Hendrik P. N., et al.
Publicado: (2009)

Monitoring for neovascular age-related macular degeneration (AMD) reactivation at home: the MONARCH study
por: Ward, Elizabeth, et al.
Publicado: (2020)

Prevalence of Geographic Atrophy in Advanced Age-Related Macular Degeneration (AMD) in Daily Practice
por: Abdin, Alaa Din, et al.
Publicado: (2023)

Chemoprevention of age-related macular regeneration (AMD) with rapamycin
por: Zheng, X. F. Steven
Publicado: (2012)

What effects has the cataract surgery on the development and progression of Age-Related Macular Degeneration (AMD)?
por: Bockelbrink, Angelina, et al.
Publicado: (2006)

Epidemiology of age-related macular degeneration (AMD): associations with cardiovascular disease phenotypes and lipid factors
por: Pennington, Katie L., et al.
Publicado: (2016)

Role of Mitochondrial DNA Damage in ROS-Mediated Pathogenesis of Age-Related Macular Degeneration (AMD)
por: Kaarniranta, Kai, et al.
Publicado: (2019)

Inner blood-retina barrier involvement in dry age-related macular degeneration (AMD) pathology
por: Hudson, Natalie, et al.
Publicado: (2020)

Potential Role of Myeloid-Derived Suppressor Cells (MDSCs) in Age-Related Macular Degeneration (AMD)
por: Kauppinen, Anu, et al.
Publicado: (2020)

Ocular Therapeutics and Molecular Delivery Strategies for Neovascular Age-Related Macular Degeneration (nAMD)
por: Sarkar, Aira, et al.
Publicado: (2021)

Neovascular Age-Related Macular Degeneration (nAMD): A Review of Emerging Treatment Options
por: Tan, Colin S, et al.
Publicado: (2022)

CFH Y402H and ARMS2 A69S Polymorphisms and Oral Supplementation with Docosahexaenoic Acid in Neovascular Age-Related Macular Degeneration Patients: The NAT2 Study
por: Merle, Bénédicte M. J., et al.
Publicado: (2015)

Human plasma metabolomics in age-related macular degeneration (AMD) using nuclear magnetic resonance spectroscopy
por: Laíns, Inês, et al.
Publicado: (2017)

Exogenous CFH Modulates Levels of Pro-Inflammatory Mediators to Prevent Oxidative Damage of Retinal Pigment Epithelial Cells with the At-Risk CFH Y402H Variant
por: Velazquez-Soto, Henry, et al.
Publicado: (2023)

Role of antioxidant enzymes and small molecular weight antioxidants in the pathogenesis of age-related macular degeneration (AMD)
por: Tokarz, Paulina, et al.
Publicado: (2013)

Potential of Induced Pluripotent Stem Cells (iPSCs) for Treating Age-Related Macular Degeneration (AMD)
por: Fields, Mark, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_50r5d49ims122hcbvjqhc6rt49